61%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
61%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
61%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
61%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
CRISPR Therapeutics AG
Closed
Sector Healthcare
41.44 2.32
Overview
Share price change
24h
Min
40.5
Max
42.27
Recommendations | Buy |
|---|---|
12 Months Forecast | +62.23 upside |
Next Earnings | 19 Feb 2025 |
|---|
News Sentiment
By Acuity
46%
54%
157 / 392 Healthcare
Technical Score
By Trading Central
Confidence
Bearish Evidence
CRISPR Therapeutics AG Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
CRISPR Therapeutics AG Forecast
Price Target
By TipRanks
62.23% upside
12 Months Forecast
Average 65.75 USD 62.23%
High 105 USD
Low 30 USD
Based on 20 Wall Street analysts offering 12 month price targets forCRISPR Therapeutics AG - Dist in the last 3 months.
Sentiment
By Acuity
157 / 392 Healthcare
News Sentiment
Bullish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Financials
$
